The role of phospholipase D1 in liver fibrosis induced by dimethylnitrosamine in vivo

Digestive Diseases and Sciences

Volumn 59, Issue 8, 2014, Pages 1779-1788

  Zhu, Xinyan ^a   Liu, Ruilin ^a   Kuang, Dapeng ^a   Liu, Jingqi ^a   Shi, Xiaomeng ^a   Zhang, Tingting ^a   Zeng, Yu ^a   Sun, Xianghua ^a   Zhang, Yi ^a   Yang, Wenzhuo ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Dimethylnitrosamine; Liver fibrosis; N methylethanolamine; Phospholipase D

Indexed keywords

2 METHYLAMINOETHANOL; ALANINE AMINOTRANSFERASE; ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; BILIRUBIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1A1; DIMETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; GELATINASE A; GELATINASE B; HYDROXYPROLINE; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHOLIPASE D1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; IN VIVO STUDY; LIVER FIBROSIS; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SPLEEN WEIGHT;

ACTINS; ANIMALS; DIMETHYLNITROSAMINE; DISEASE PROGRESSION; DOWN-REGULATION; LIVER; LIVER CIRRHOSIS; MALE; PHOSPHOLIPASE D; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84905588562     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3130-6     Document Type: Article

References (42)

1. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. (Pubitemid 351615417)
2. McDermott M, Wakelam MJ, Morris AJ. Phospholipase D. Biochem Cell Biol. 2004;82:225-253.
3. Liscovitch M, Czarny M, Fiucci G, et al. Phospholipase D: molecular and cell biology of a novel gene family. Biochem J. 2000;345:401-415. (Pubitemid 30099066)
4. Exton JH. Phospholipase D-structure, regulation and function. Rev Physiol Biochem Pharmacol. 2002;144:1-94.
5. Jenkins GM, Frohman MA. Phospholipase D a lipid centric review. Cell Mol Life Sci. 2005;62:2305-2316.
6. Roth MG. Molecular mechanisms of PLD function in membrane traffic. Traffic. 2008;9:1233-1239. (Pubitemid 352016283)
7. Komati H, Naro F, Mebarek S, et al. Phospholipase D is involved in myogenic differentiation through remodeling of actin cyto-skeleton. Mol Biol Cell. 2005;16:1232-1244. (Pubitemid 40349560)
8. Rudge SA, Wakelam MJ. Inter-regulatory dynamics of phospholipase D and the actin cytoskeleton. Biochim Biophys Acta. 2009;1791:856-861.
9. Chae YC, Kim JH, Kim KL, et al. Phospholipase D activity regulates integrin-mediated cell spreading and migration by inducing GTP-Rac translocation to the plasma membrane. Mol Biol Cell. 2008;19:3111-3123.
10. Horstmeyer A, Licht C, Scherr G, et al. Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1. FEBS J. 2005;272:6297-6309. (Pubitemid 41815618)
11. Andersson L, Bostrom P, Ericson J, et al. PLD1 and ERK2 regulate cytosolic lipid droplet formation. J Cell Sci. 2006;119:2246-2257. (Pubitemid 43960314)
12. Marchesan D, Rutberg M, Andersson L, et al. A phospholipase D-dependent process forms lipid droplets containing caveolin, adipocyte differentiation- related protein, and vimentin in a cell-free system. J Biol Chem. 2003;278:27293-27300. (Pubitemid 36876887)
13. Lee S, Park JB, Kim JH, et al. Actin directly interacts with phospholipase D, inhibiting its activity. J Biol Chem. 2001;276:28252-28260.
14. Kam Y, Exton JH. Phospholipase D activity is required for actin stress fiber formation in fibroblasts. Mol Cell Biol. 2001;21:4055-4066. (Pubitemid 32476466)
15. Pilquil C, Dewald J, Cherney A, et al. Lipid phosphate phosphatase-1 regulates lysophosphatidate-induced fibroblast migration by controlling phospholipase D2-dependent phosphatidate generation. J Biol Chem. 2006;281:38418-38429. (Pubitemid 46041965)
16. Yamamoto K, Takahashi Y, Mano T, et al. N-methylethanolamine attenuates cardiac fibrosis and improves diastolic function: inhibition of phospholipase D as a possible mechanism. Eur Heart J. 2004;25:1221-1229. (Pubitemid 38891572)
17. Baroni GS, D'Ambrosio L, Curto P, et al. Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology. 1996;23:1189-1199. (Pubitemid 26137066)
18. Brunt EM. Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology. 2000;31:241-246. (Pubitemid 30033714)
19. Itoh S, ten Dijke P. Negative regulation of TGF-beta receptor/Smad signal transduction. Curr Opin Cell Biol. 2007;19:176-184. (Pubitemid 46386411)
20. Hu P-F, Zhu Y-W, Zhong W, et al. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol. 2008;23:1917-1925.
21. Trebicka J, Racz I, Siegmund SV, et al. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts. Liver Int. 2011;31:860-870.
22. Benitez-Rajal J, Lorite MJ, Burt AD, et al. Phospholipase D and extracellular signal-regulated kinase in hepatic stellate cells: effects of platelet-derived growth factor and extracellular nucleotides. Am J Physiol Gastrointest Liver Physiol. 2006;291:G977-G986. (Pubitemid 44772024)
23. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med. 2007;13:1324-1332. (Pubitemid 350073596)
24. Du G, Altshuller YM, Kim Y, et al. Dual requirement for rho and protein kinase C in direct activation of phospholipase D1 through G protein-coupled receptor signaling. Mol Biol Cell. 2000;11:4359-4368.
25. Colley WC, Sung TC, Roll R, et al. Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization. Curr Biol. 1997;7:191-201. (Pubitemid 27164725)
26. Du G, Huang P, Liang BT, et al. Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. Mol Biol Cell. 2004;15:1024-1030. (Pubitemid 38316213)
27. Freyberg Z, Sweeney D, Siddhanta A, et al. Intracellular localization of phospholipase D1 in mammalian cells. Mol Biol Cell. 2001;12:943-955. (Pubitemid 33051990)
28. Noh DY, Ahn SJ, Lee RA, et al. Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett. 2000;161:207-214.
29. Wood LD, Parsons DW, Jones S, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108-1113. (Pubitemid 350134889)
30. Saito M, Iwadate M, Higashimoto M, et al. Expression of phospholipase D2 in human colorectal carcinoma. Oncol Rep. 2007;18:1329-1334.
31. Zhao Y, Ehara H, Akao Y, et al. Increased activity and intranuclear expression of phospholipase D2 in human renal cancer. Biochem Biophys Res Commun. 2000;278:140-143.
32. Cai D, Zhong M, Wang R, et al. Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci USA. 2006;103:1936-1940. (Pubitemid 43228796)
33. Gorbatyuk OS, Li S, Nha Nguyen F, et al. Alpha-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. Mol Ther. 2010;18:1758-1768.
34. Oliveira TG, Chan RB, Tian H, et al. Phospholipase d2 ablation ameliorates Alzheimer's disease-linked synaptic dysfunction and cognitive deficits. J Neurosci. 2010;30:16419-16428.
35. Zhang Y, Kanaho Y, Frohman MA, et al. Phospholipase D1-promoted release of tissue plasminogen activator facilitates neurite outgrowth. J Neurosci. 2005;25:1797-1805. (Pubitemid 40279285)
36. Vorland M, Holmsen H. Phospholipase D in human platelets: presence of isoenzymes and participation of autocrine stimulation during thrombin activation. Platelets. 2008;19:211-224. (Pubitemid 351574443)
37. Vorland M, Holmsen H. Phospholipase D activity in human platelets is inhibited by protein kinase A, involving inhibition of phospholipase D1 translocation. Platelets. 2008;19:300-307. (Pubitemid 351874160)
38. Su W, Chen Q, Frohman MA. Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 2009;5:1477-1486.
39. Elvers M, Stegner D, Hagedorn I, et al. Impaired alpha(IIb)-beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1. Sci Signal. 2010;3:ra1.
40. Hong KW, Jin HS, Lim JE, et al. Non-synonymous singlenucleotide polymorphisms associated with blood pressure and hypertension. J Hum Hypertens. 2010;24:763-774.
41. Tsukahara T, Tsukahara R, Fujiwara Y, et al. Phospholipase D2-dependent inhibition of the nuclear hormone receptor PPAR-gamma by cyclic phosphatidic acid. Mol Cell. 2010;39:421-432.
42. Disse J, Vitale N, Bader MF, et al. Phospholipase D1 is specifically required for regulated secretion of von Willebrand factor from endothelial cells. Blood. 2009;113:973-980.